Key Drivers
- Margin Compression
- Rising Leverage
- Positive Cash Flow
AIAI Summary
COLL is a leveraged ADHD-platform transition—not a simple value play—where JORNAY PM and AZSTARYS growth can unlock significant upside only if margin recovery and free-cash-flow-driven deleveraging materially improve interest coverage; investors should prioritize quarterly EBITDA, cash conversion, and net-debt reduction over buybacks.
Price Chart
Financial Metrics
Deep Analysis
Research tool. Not personalized advice.
Fundamental Analysis
Key Financial Insights:
- •Margin Compression
- •Rising Leverage
- •Positive Cash Flow
COLL's strong FY2025 profitability has deteriorated sharply into a quarterly loss with weaker margins, strained liquidity, and higher leverage, despite positive operating cash flow.
Price Behavior
Key Price Behavior Insights:
- •Lower highs
- •Three-day rebound
- •Key support
COLL remains in a bearish last-month trend despite a tentative three-day rebound; hold above $21.84, but a move through $23.36–$23.70 is needed to confirm stabilization.
Three consecutive daily gains from $21.84 to $22.77 signal a tentative bounce
Sentiment & News
Key News Insights:
- •BlackRock stake
- •Price decline
- •Investor engagement
- •News View: Large institutional positions may support sentiment, but near-term share performance remains volatile.
Collegium shares weakened despite major new institutional buying and ongoing investor outreach, signaling improved long-term interest amid near-term pressure.
Similar Companies in Healthcare
Other companies in the same sector with AI ratings